MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-KR-03-0093484
Acurela Pharms Limited
Acurela Pharms Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.83 Cr
▲ 54% YoY
Net loss · FY 2025
₹1.15 Cr
Net margin -62.9%
EBITDA · FY 2025
-₹1.55 Cr
EBITDA margin -84.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Employees · EPFO
27
Provident fund records
Directors on board
3
As per MCA filings
About Acurela Pharms Limited
Data last updated:
Acurela Pharms Limited is a public limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2021PLC149702. Its GSTIN is 29AAVCA5089P1ZF (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Thushar Shivapura Gangadhar (Managing Director) and Shivapura Bhadraiah Gangadhar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #1335 3rd Cross M R H B Colony Vijaynagar, Bangalore, Karnataka, India – 560079.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.83 Cr, a growth of 54% compared to the previous year. For the same year it recorded a net loss of ₹1.15 Cr (net margin -62.9%) and EBITDA of -₹1.55 Cr (EBITDA margin -84.9%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years.
The company has about 27 employees on its provident fund (EPFO) records.
Acurela Pharms Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0093484).
Company details
CIN U24290KA2021PLC149702
Registration Number 149702
Incorporation Date 20 July 2021
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0093484
Key People
Thushar Shivapura Gangadhar Managing Director Shivapura Bhadraiah Gangadhar Director Latha Gangadhar Director Recognitions & Rankings of Acurela Pharms
Contact details
Acurela Pharms Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address#1335 3rd Cross M R H B Colony Vijaynagar, Bangalore, Karnataka, India – 560079
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Acurela Pharms Limited, buy the company report.
Comprehensive company report
Acurela Pharms Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Acurela Pharms is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Acurela Pharms Limited, buy the company report.
Financials of Acurela Pharms Limited
FY 2025 filings availableAcurela Pharms Limited reported revenue of ₹1.83 Cr (up 54% YoY) for FY 2025.
Revenue · FY 2025
₹1.83 Cr ▲ 54%
Net loss · FY 2025
₹1.15 Cr margin -62.9%
EBITDA · FY 2025
-₹1.55 Cr margin -84.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 72%
3 years · compounded
▼ 104%
Revenue has grown at a compounded annual rate (CAGR) of 16% over three years, including 54% growth in the latest year. EBITDA rose 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.55 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.15 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -84.9% | |||
| Net Profit Margin | -62.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Acurela Pharms Limited, buy the company report.
Board of directors of Acurela Pharms Limited
Acurela Pharms has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivapura Bhadraiah Gangadhar Also directs: Acurela Health Limited | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
| Latha Gangadhar Also directs: Acurela Health Limited | Director | 01 Nov 2024 | 1 Years 11 Months | Current |
| Thushar Shivapura Gangadhar Also directs: Acurela Health Limited | Managing Director | 20 Jul 2021 | 5 Years 3 Months | Current |
Peer comparison
Acurela Pharms Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medreich Life Care Limited | ₹1.83 Cr (FY 2022) | -47.0% | Bangalore, Karnataka, India | |||
| Acurela Pharms Limitedthis company | ₹1.83 Cr (FY 2025) | -₹1.15 Cr | -62.9% | 54.0% | 27 | Bangalore, Karnataka, India |
| Jak Pharmalab Private Limited | ₹1.82 Cr (FY 2024) | -31.0% | Mumbai, Maharashtra, India | |||
| Carneo Pharma (OPC) Private Limited | ₹1.82 Cr (FY 2025) | 214.0% | Pune, Maharashtra, India | |||
| SM Traders Private Limited | ₹1.82 Cr (FY 2025) | 68.0% | Ernakulam, Kerala, India | |||
| Sinopharm India Private Limited | ₹1.82 Cr (FY 2024) | -66.0% | New Delhi, Delhi, India |
To see the full peer comparison of Acurela Pharms Limited, buy the company report.
Auditor
Acurela Pharms Limited is audited by R. RAMAKRISHNA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. RAMAKRISHNA | FY 2023 | 024348 |
Shareholding
The shareholding of Acurela Pharms Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Acurela Pharms Limited, buy the company report.
Legal cases
No court or tribunal cases involving Acurela Pharms Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Acurela Pharms Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Acurela Pharms Limited has a workforce of 27 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
27
Active EPFO establishments
1
Employee growth
-3.57%
GST
Acurela Pharms has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAVCA5089P1ZF | Karnataka | Active | 06 Aug 2021 |
To see the full GST registrations and return filing status of Acurela Pharms Limited, buy the company report.
Recent activity
Acurela Pharms Limited has 5 board changes on record since 2021: 3 appointments and 2 cessations. The latest: Chinnappa Ramakrishna Shankar ceased to be Director on 08 Nov 2024.
AGM
Acurela Pharms Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Acurela Pharms Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Chinnappa Ramakrishna Shankar ceased to be Director.
Appointed
Latha Gangadhar was appointed as Director.
Ceased
Thushar Shivapura Gangadhar ceased to be Director.
Appointed
Shivapura Bhadraiah Gangadhar was appointed as Director.
Appointed
Thushar Shivapura Gangadhar was appointed as Managing Director.
Incorporation
20 Jul 2021
Acurela Pharms Limited was registered on 20 Jul 2021 with Roc Bangalore & aged 5 years 3 months as per MCA records.
Frequently asked questions
Acurela Pharms is an active public limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 July 2021 (5+ years old) and is registered under CIN U24290KA2021PLC149702.
Acurela Pharms has 3 current directors:
- Thushar Shivapura Gangadhar - Managing Director
- Shivapura Bhadraiah Gangadhar - Director
- Latha Gangadhar - Director
The latest financial statements of Acurela Pharms on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Acurela Pharms is 29AAVCA5089P1ZF, registered in Karnataka.
The CIN (Corporate Identification Number) of Acurela Pharms is U24290KA2021PLC149702. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acurela Pharms was incorporated on 20 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Acurela Pharms by revenue are Medreich Life Care Limited, Jak Pharmalab Private Limited, Carneo Pharma (OPC) Private Limited, SM Traders Private Limited, Sinopharm India Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Chinnappa Ramakrishna Shankar ceased to be Director on 08 Nov 2024. Latha Gangadhar was appointed as Director on 01 Nov 2024. Thushar Shivapura Gangadhar ceased to be Director on 09 Oct 2021. Acurela Pharms has 5 board changes on record in total.
Yes, Acurela Pharms is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0093484).
The registered office of Acurela Pharms is at #1335 3rd Cross M R H B Colony Vijaynagar, Bangalore, Karnataka, India – 560079.
Acurela Pharms operates in the pharma industry, in the pharmaceutical retailers and distributors segment.